UKHSA (UK) · Jun 16, 2026
Research: Hantavirus: vaccine effectiveness following Andes virus exposure
Evidence of the protective efficacy of vaccines for hantavirus in people or animals exposed to Andes virus.
Latest medical news · page 182
The latest headlines across every section, pulled from official and open-access sources.
FDA MedWatch · Jun 16, 2026
Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers
The FDA issued a LHCP to notify providers that Stereotactic Breast Biopsy Needles (product code KNW) are experiencing a supply disruption.
CDC Emerging Infections · Jun 16, 2026
Epidemiology and Clinical Features of Balamuthia mandrillaris Infection, China
T. Yang et al.
FDA MedWatch · Jun 16, 2026
Early Alert: Convenience Kit Issue from Windstone Medical Packaging, Inc.
Certain Cardinal Health Webcol Large Alcohol Prep Pads in Custom Convenience Kits manufactured by Aligned Medical Solutions are not sterile
JAMA Network Open · Jun 16, 2026
Optimizing Contraceptive Effectiveness—Lessons From HER Salt Lake
Obstetrics and Gynecology
JAMA Network Open · Jun 16, 2026
Dementia and Hip Fracture Recovery
Geriatrics
JAMA Network Open · Jun 16, 2026
Narrow Networks and Coverage Changes Among Medicare Advantage Beneficiaries With Cancer
Health Policy
JAMA Network Open · Jun 16, 2026
Three-Year Contraceptive Failure Rates in the HER Salt Lake Contraceptive Initiative
This cohort study assesses 3-year continuation and typical-use contraceptive failure rates for 7 highly effective reversible (HER) contraceptive methods.
JAMA Network Open · Jun 16, 2026
Group Interpersonal Psychotherapy for Depression in Perinatal Adolescents
This randomized clinical trial evaluates the feasibility and preliminary effectiveness of task-shifted delivery of full and mini versions of group interpersonal psychotherapy for depression among perinatal adolescents in Kenya.
JAMA Network Open · Jun 16, 2026
Days at Home After Hip Fracture Among Older Adults With and Without Dementia
This cohort study evaluates days at home and survival for the year after hip fracture among older adults with and without dementia.
JAMA Network Open · Jun 16, 2026
Access to Specialty Cancer Care and Plan Disenrollment Among Medicare Beneficiaries
This cohort study investigates the association of access to specialized cancer care with plan disenrollment among Medicare Advantage enrollees with new cancer diagnoses.
JAMA Network Open · Jun 16, 2026
Metabolic Bariatric Surgery Uptake Among US Adults With Obesity
This cohort study uses insurance claims data to examine factors associated with uptake of metabolic bariatric surgery among individuals with an incident obesity diagnosis.
JAMA Network Open · Jun 16, 2026
Short-Acting Opioids and Patient-Directed Discharge in Patients With OUD
This cohort study of hospitalized adults with opioid use disorder examines whether there is an association of timing and dose of short-acting opioids for opioid withdrawal syndrome with early patient-directed discharge.
JAMA Network Open · Jun 16, 2026
Policy and Payment Factors in Adoption of Low-Barrier Buprenorphine Treatment
This qualitative study explores the perspectives of opioid use disorder (OUD) treatment program clinicians and staff about how broader policy and payment structures affect adoption of buprenorphine treatment and low-barrier care practices that promote access and retention.
MedCity News · Jun 15, 2026
Multicare CFO: Decades of CMS Underpayment is Creating an Unfair Two-Tiered System
MultiCare CFO James Lee said decades of government underpayment have pushed U.S. healthcare to a breaking point. He thinks the nation is headed toward a two-tier system — one for patients with commercial coverage, and another for those covered through CMS. The post Multicare CFO: Decades of CMS Underpayment is Creating an Unfair Two-Tiered System appeared first on MedCity News .
MedCity News · Jun 15, 2026
Elevance Health’s 3 Key Priorities for AI
Elevance Health is leveraging AI for simplifying the member experience, improving the provider experience and making sure employees have the right information at the right time. The post Elevance Health’s 3 Key Priorities for AI appeared first on MedCity News .
ACP · Jun 15, 2026
ACP issues new living clinical guideline on using medications to manage overweight and obesity
PHILADELPHIA, June 15, 2026 – The American College of Physicians (ACP) has issued a new living clinical guideline to help physicians choose medications with lifestyle modifications to manage overweight and obesity in adults. “ Pharmacologic Treatments with Lifestyle Modifications in Nonpregnant Adults with Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline from the American College of Physicians” is published in Annals of Internal Medicine . More than half (59%) of the world’s population has overweight or obesity, chronic conditions…
FDA Newsroom · Jun 15, 2026
FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
On June 12, 2026, the U.S. Food and Drug Administration granted accelerated approval to Tzield (teplizumab) for a new indication, to delay the decline of insulin production in pediatric patients ages 8 through 17 years who have been recently diagnosed with Stage 3 type 1 diabetes (T1D).
MedCity News · Jun 15, 2026
Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med
Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in development for myelofibrosis, came from Lilly’s acquisition of biotech startup Ajax Therapeutics. The post Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med appeared first on MedCity News .
MHRA (UK) · Jun 15, 2026
Unique liaison programme set to reinforce close collaboration between MHRA and FDA
MHRA and FDA liaison programme announced to improve regulatory collaboration and support long-standing international partnership.
FDA Drugs · Jun 15, 2026
Frequently Asked Questions About Drugs
Frequently Asked Questions About Drugs
FDA Drugs · Jun 15, 2026
Development of Antihypertensive Therapies for Use in Pediatric Patients - 07/15/2026
Treatment of chronic hypertension (high blood pressure) in pediatric patients remains an area of unmet medical need, with limited FDA-approved therapies, particularly for children younger than six years of age. Products are being developed to treat uncontrolled and/or resistant hypertension in adults that may have benefits in pediatric patients.
FDA Recalls · Jun 15, 2026
Western Mixers Produce & Nuts Issues Allergy Alert on Undeclared Peanuts in First Street Brand, Dark Chocolate Raisins
Western Mixers Produce & Nuts, Inc., Ontario, California is recalling: First Street brand, Dark Chocolate Raisins, 9 oz., because the product may contain undeclared dark chocolate peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergi
FDA Drugs · Jun 15, 2026
Outsourcing Facilities Annual Study
Compounding Outsourcing Facilities Annual Study